Literature DB >> 12089442

Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Jason P Eiserich1, Stephan Baldus, Marie-Luise Brennan, Wenxin Ma, Chunxiang Zhang, Albert Tousson, Laura Castro, Aldons J Lusis, William M Nauseef, C Roger White, Bruce A Freeman.   

Abstract

Myeloperoxidase (MPO) is an abundant mammalian phagocyte hemoprotein thought to primarily mediate host defense reactions. Although its microbicidal functions are well established in vitro, humans deficient in MPO are not at unusual risk of infection. MPO was observed herein to modulate the vascular signaling and vasodilatory functions of nitric oxide (NO) during acute inflammation. After leukocyte degranulation, MPO localized in and around vascular endothelial cells in a rodent model of acute endotoxemia and impaired endothelium-dependent relaxant responses, to which MPO-deficient mice were resistant. Altered vascular responsiveness was due to catalytic consumption of NO by substrate radicals generated by MPO. Thus MPO can directly modulate vascular inflammatory responses by regulating NO bioavailability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089442     DOI: 10.1126/science.1106830

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  188 in total

1.  Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia.

Authors:  Juhi Shukla; Scott W Walsh
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

2.  Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.

Authors:  W H Wilson Tang; Yuping Wu; Jaana Hartiala; Yiying Fan; Alexandre F R Stewart; Robert Roberts; Ruth McPherson; Paul L Fox; Hooman Allayee; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 3.  Myeloperoxidase production by macrophage and risk of atherosclerosis.

Authors:  Mahir Karakas; Wolfgang Koenig
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 4.  Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Authors:  Mehdi H Shishehbor; Stanley L Hazen
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

5.  Aminobenzoic acid hydrazide, a myeloperoxidase inhibitor, alters the adhesive properties of neutrophils isolated from acute myocardial infarction patients.

Authors:  Lili Han; Xiaoli Shen; Leng Pan; Saimei Lin; Xiaoqing Liu; Yulian Deng; Xiaodong Pu
Journal:  Heart Vessels       Date:  2011-08-12       Impact factor: 2.037

6.  Comparison of ischemic preconditioning and BotulinumA Toxin injection for the prevention of ischemia-reperfusion injury in musculocutaneous flaps

Authors:  Handan Derebaşınlıoğlu; Anil Demİröz; Yağmur Aydin; Hakan Ekmekçi; Özlem Balci Ekmekçi; Övgü Aydin; Levent Cankorkmaz
Journal:  Turk J Med Sci       Date:  2020-10-22       Impact factor: 0.973

7.  Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.

Authors:  Benjamin M Scirica; Marc S Sabatine; Petr Jarolim; Sabina A Murphy; James L de Lemos; Eugene Braunwald; David A Morrow
Journal:  Eur Heart J       Date:  2010-12-22       Impact factor: 29.983

Review 8.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

9.  High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk.

Authors:  Jing Li; Andreas J Flammer; Martin K Reriani; Yoshiki Matsuo; Rajiv Gulati; Paul A Friedman; Randal J Thomas; Nicole P Sandhu; Lilach O Lerman; Amir Lerman
Journal:  Circ J       Date:  2012-12-06       Impact factor: 2.993

10.  Cytoglobin is expressed in the vasculature and regulates cell respiration and proliferation via nitric oxide dioxygenation.

Authors:  Katharine E Halligan; Frances L Jourd'heuil; David Jourd'heuil
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.